2 completed, 1 active not recruiting. 2 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Hyewon Chung: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial to Evaluate the Effect of Grapefruit Juice on the PK/PD of Edoxaban Edoxaban 60 MG [Lixiana], Edoxaban 60 MG [Lixiana] + Grapefruit Juice - Healthy | Phase 1 | Active not recruiting | Hyewon Chung | 14 | 2025-09-02 | 2025-09-16 |
| A Clinical Trial to Evaluate the Effect of Nilotinib on the PK/PD of Meformin Metformin, Metformin + Nilotinib - Healthy | Phase 1 | Completed | Hyewon Chung | 16 | 2020-07-23 | 2020-11-04 |
| Changes in Inflammatory Biomarkers Including Soluble CD14 and Hyperreflective Foci in DME Patients Treated With Aflibercept (FORESIGHT) Aflibercept Injection - Diabetic Macular Edema | Phase 4 | Completed | Hyewon Chung | 23 | 2019-05-17 | 2024-05-29 |
Metformin (1) · aflibercept (1) · edoxaban (1) · nilotinib (1)
South Korea (3)